Nu Skin Enterprises, Inc. (NUS) Upgraded to “Buy” by ValuEngine

ValuEngine upgraded shares of Nu Skin Enterprises, Inc. (NYSE:NUS) from a hold rating to a buy rating in a report released on Tuesday morning.

NUS has been the topic of a number of other research reports. TheStreet upgraded Nu Skin Enterprises from a c+ rating to a b rating in a report on Wednesday, August 2nd. Zacks Investment Research lowered Nu Skin Enterprises from a buy rating to a hold rating in a report on Thursday, October 5th. Stifel Nicolaus set a $50.00 price target on Nu Skin Enterprises and gave the stock a sell rating in a report on Thursday, August 3rd. Finally, BidaskClub lowered Nu Skin Enterprises from a strong-buy rating to a buy rating in a report on Monday, July 31st. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the stock. Nu Skin Enterprises presently has a consensus rating of Hold and an average target price of $62.00.

Shares of Nu Skin Enterprises (NYSE:NUS) traded down $0.58 during trading on Tuesday, reaching $63.04. The company’s stock had a trading volume of 413,400 shares, compared to its average volume of 680,447. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises has a 12-month low of $46.35 and a 12-month high of $65.85. The firm has a market capitalization of $3,349.59, a PE ratio of 22.48, a PEG ratio of 2.31 and a beta of 1.57.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Wednesday, November 1st. The company reported $0.76 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.76. Nu Skin Enterprises had a return on equity of 22.38% and a net margin of 6.97%. The firm had revenue of $563.70 million during the quarter, compared to analysts’ expectations of $562.70 million. During the same quarter last year, the firm posted $0.98 earnings per share. The company’s revenue for the quarter was down 6.7% compared to the same quarter last year. analysts expect that Nu Skin Enterprises will post 3.23 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This report was first reported by Markets Daily and is owned by of Markets Daily. If you are viewing this report on another domain, it was copied illegally and reposted in violation of United States & international trademark and copyright laws. The legal version of this report can be accessed at https://www.themarketsdaily.com/2017/11/15/nu-skin-enterprises-inc-nus-upgraded-to-buy-by-valuengine.html.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 6th. Shareholders of record on Friday, November 17th will be paid a $0.36 dividend. The ex-dividend date is Thursday, November 16th. This represents a $1.44 annualized dividend and a dividend yield of 2.28%. Nu Skin Enterprises’s payout ratio is presently 52.75%.

In other news, insider Joseph Y. Chang sold 13,497 shares of Nu Skin Enterprises stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $62.06, for a total value of $837,623.82. Following the completion of the transaction, the insider now directly owns 66,563 shares in the company, valued at $4,130,899.78. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Daniel W. Campbell sold 4,607 shares of Nu Skin Enterprises stock in a transaction on Thursday, September 7th. The shares were sold at an average price of $62.48, for a total value of $287,845.36. Following the completion of the transaction, the director now owns 63,753 shares of the company’s stock, valued at $3,983,287.44. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 73,207 shares of company stock worth $4,585,949. Corporate insiders own 5.20% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the company. US Bancorp DE grew its position in shares of Nu Skin Enterprises by 3.3% in the second quarter. US Bancorp DE now owns 2,032 shares of the company’s stock valued at $128,000 after purchasing an additional 65 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. purchased a new position in shares of Nu Skin Enterprises in the third quarter valued at $148,000. CENTRAL TRUST Co purchased a new position in Nu Skin Enterprises during the second quarter worth about $187,000. Pillar Pacific Capital Management LLC purchased a new position in Nu Skin Enterprises during the second quarter worth about $202,000. Finally, Ronald Blue & Co. LLC purchased a new position in Nu Skin Enterprises during the second quarter worth about $207,000. Institutional investors own 80.13% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply